Form 4 for ENVA Enova International, Inc.
Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-08 · accession 0000899243-22-005685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-10 | 2022-02-08 | ENVA | Cunningham Steven E | CFO | A - Grant | $0.00 | +47.0K | 219.6K | +27% | $0 |
| D | 2022-02-10 | 2022-02-08 | ENVA | Cunningham Steven E | CFO | A - Grant | $0.00 | +10.3K | 236.6K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 | 2022-02-08 | A | A | 47,028 | $0.00 | 219,577 | D | — | — | (F1) This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026. |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) with limited SAR | 2022-02-08 | A | A | 10,298 | $0.00 | 236,597 | D | $45.00 · — to 2029-02-08 | 10,298 Common stock, par value $0.00001 per share | (F3) The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. (F2) The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. (F4) The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025. |